SPRB
Spruce Biosciences, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$135.15M
P/E Ratio
—
EPS
$-35.82
Beta
3.20
52W High
$240.00
52W Low
$4.77
50-Day MA
$56.79
200-Day MA
$70.62
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Spruce Biosciences, Inc. Common Stock
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company is headquartered in Daly City, California.
Fundamentals
| Revenue (TTM) | 697,000 |
| Gross Profit (TTM) | $-10.36M |
| EBITDA | $-25.84M |
| Operating Margin | 0.00% |
| Return on Equity | -148.80% |
| Return on Assets | -37.20% |
| Revenue/Share (TTM) | $1.20 |
| Book Value | $30.99 |
| Price-to-Book | 3.89 |
| Price-to-Sales (TTM) | 49.19 |
| EV/Revenue | 77.32 |
| EV/EBITDA | -0.23 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -75.90% |
| Shares Outstanding | $2.75M |
| Float | $2.65M |
| % Insiders | 3.51% |
| % Institutions | 31.07% |
Historical Volatility
HV 10-Day
69.08%
HV 20-Day
73.44%
HV 30-Day
62.17%
HV 60-Day
94.43%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($154.17 target)
1
Strong Buy4
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026